Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Elimination of Epidemic Meningitis in the African Region: Progress and Challenges: 2010-2016.

Fall A, Bita AF, Lingani C, Djingarey M, Tevi-Benissan C, Preziosi MP, Ronveaux O, Mihigo R, Okeibunor J, Akanmori BD.

J Immunol Sci. 2018 Jul 2;Suppl:41-45.

2.

Meningococcus serogroup C clonal complex ST-10217 outbreak in Zamfara State, Northern Nigeria.

Kwambana-Adams BA, Amaza RC, Okoi C, Rabiu M, Worwui A, Foster-Nyarko E, Ebruke B, Sesay AK, Senghore M, Umar AS, Usman R, Atiku A, Abdullahi G, Buhari Y, Sani R, Bako HU, Abdullahi B, Yarima AI, Sikiru B, Moses AO, Popoola MO, Ekeng E, Olayinka A, Mba N, Kankia A, Mamadu IN, Okudo I, Stephen M, Ronveaux O, Busuttil J, Mwenda JM, Abdulaziz M, Gummi SA, Adedeji A, Bita A, Omar L, Djingarey MH, Alemu W, D'Alessandro U, Ihekweazu C, Antonio M.

Sci Rep. 2018 Sep 21;8(1):14194. doi: 10.1038/s41598-018-32475-2.

3.

Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.

Mengesha Tsegaye M, Beyene B, Ayele W, Abebe A, Tareke I, Sall A, Yactayo S, Shibeshi ME, Staples E, Belay D, Lilay A, Alemu A, Alemu E, Kume A, H/Mariam A, Ronveaux O, Tefera M, Kassa W, Bekele Weyessa A, Jima D, Kebede A, Tayachew A.

BMC Public Health. 2018 Aug 14;18(1):1011. doi: 10.1186/s12889-018-5726-9.

4.

Reactive vaccination as a control strategy for pneumococcal meningitis outbreaks in the African meningitis belt: Analysis of outbreak data from Ghana.

Cooper LV, Stuart JM, Okot C, Asiedu-Bekoe F, Afreh OK, Fernandez K, Ronveaux O, Trotter CL.

Vaccine. 2018 Jan 20. pii: S0264-410X(17)31832-7. doi: 10.1016/j.vaccine.2017.12.069. [Epub ahead of print]

5.

Large Outbreak of Neisseria meningitidis Serogroup C - Nigeria, December 2016-June 2017.

Nnadi C, Oladejo J, Yennan S, Ogunleye A, Agbai C, Bakare L, Abdulaziz M, Mohammed A, Stephens M, Sumaili K, Ronveaux O, Maguire H, Karch D, Dalhat M, Antonio M, Bita A, Okudo I, Nguku P, Novak R, Bolu O, Shuaib F, Ihekweazu C.

MMWR Morb Mortal Wkly Rep. 2017 Dec 15;66(49):1352-1356. doi: 10.15585/mmwr.mm6649a3.

6.

[Impact of Controlled Temperature Chain (CTC) approach on immunization coverage achieved during the preventive vaccination campaign against meningitis A using MenAfriVac in Togo in 2014].

Landoh DE, Kahn AL, Lacle A, Adjeoda K, Saka B, Yaya I, Nassoury DI, Kalao A, Makawa MS, Biey NJ, Bita A, Toke YT, Dörte P, Imboua L, Ronveaux O.

Pan Afr Med J. 2017 May 12;27:38. doi: 10.11604/pamj.2017.27.38.11873. eCollection 2017. French.

7.

Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.

Trotter CL, Lingani C, Fernandez K, Cooper LV, Bita A, Tevi-Benissan C, Ronveaux O, Préziosi MP, Stuart JM.

Lancet Infect Dis. 2017 Aug;17(8):867-872. doi: 10.1016/S1473-3099(17)30301-8. Epub 2017 May 22.

PMID:
28545721
8.

Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.

Sidikou F, Zaneidou M, Alkassoum I, Schwartz S, Issaka B, Obama R, Lingani C, Tate A, Ake F, Sakande S, Ousmane S, Zanguina J, Seidou I, Nzeyimana I, Mounkoro D, Abodji O, Wang X, Taha MK, Moulia-Pelat JP, Pana A, Kadade G, Ronveaux O, Novak R, Oukem-Boyer OOM, Meyer S; MenAfriNet consortium.

Lancet Infect Dis. 2016 Nov;16(11):1288-1294. doi: 10.1016/S1473-3099(16)30253-5. Epub 2016 Aug 23.

9.

Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015.

Kretz CB, Retchless AC, Sidikou F, Issaka B, Ousmane S, Schwartz S, Tate AH, Pana A, Njanpop-Lafourcade BM, Nzeyimana I, Nse RO, Deghmane AE, Hong E, Brynildsrud OB, Novak RT, Meyer SA, Oukem-Boyer OOM, Ronveaux O, Caugant DA, Taha MK, Wang X; Niger Response Team.

Emerg Infect Dis. 2016 Oct;22(10):1762-1768. doi: 10.3201/eid2210.160468.

10.

Vaccine Effectiveness of Polysaccharide Vaccines Against Clinical Meningitis - Niamey, Niger, June 2015.

Rondy M, Issifou D, Ibrahim AS, Maman Z, Kadade G, Omou H, Fati S, Kissling E, Meyer S, Ronveaux O.

PLoS Curr. 2016 Apr 18;8. pii: ecurrents.outbreaks.5d6e9c1d071a2088109c242771b68886. doi: 10.1371/currents.outbreaks.5d6e9c1d071a2088109c242771b68886.

11.

The actual and potential costs of meningitis surveillance in the African meningitis belt: Results from Chad and Niger.

Irurzun-Lopez M, Erondu NA, Djibo A, Griffiths U, Stuart JM, Fernandez K, Ronveaux O, Le Gargasson JB, Gessner BD, Colombini A.

Vaccine. 2016 Feb 17;34(8):1133-8. doi: 10.1016/j.vaccine.2015.10.045. Epub 2015 Oct 23.

PMID:
26603955
12.

Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013.

Lingani C, Bergeron-Caron C, Stuart JM, Fernandez K, Djingarey MH, Ronveaux O, Schnitzler JC, Perea WA.

Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S410-5. doi: 10.1093/cid/civ597.

13.

Response thresholds for epidemic meningitis in sub-Saharan Africa following the introduction of MenAfriVac®.

Trotter CL, Cibrelus L, Fernandez K, Lingani C, Ronveaux O, Stuart JM.

Vaccine. 2015 Nov 17;33(46):6212-7. doi: 10.1016/j.vaccine.2015.09.107. Epub 2015 Oct 14.

PMID:
26463444
14.

Chemoprophylaxis and vaccination in preventing subsequent cases of meningococcal disease in household contacts of a case of meningococcal disease: a systematic review.

Telisinghe L, Waite TD, Gobin M, Ronveaux O, Fernandez K, Stuart JM, Scholten RJ.

Epidemiol Infect. 2015 Aug;143(11):2259-68. doi: 10.1017/S0950268815000849. Epub 2015 Apr 28. Review.

PMID:
25916733
15.

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections.

WHO Ebola Response Team, Aylward B, Barboza P, Bawo L, Bertherat E, Bilivogui P, Blake I, Brennan R, Briand S, Chakauya JM, Chitala K, Conteh RM, Cori A, Croisier A, Dangou JM, Diallo B, Donnelly CA, Dye C, Eckmanns T, Ferguson NM, Formenty P, Fuhrer C, Fukuda K, Garske T, Gasasira A, Gbanyan S, Graaff P, Heleze E, Jambai A, Jombart T, Kasolo F, Kadiobo AM, Keita S, Kertesz D, Koné M, Lane C, Markoff J, Massaquoi M, Mills H, Mulba JM, Musa E, Myhre J, Nasidi A, Nilles E, Nouvellet P, Nshimirimana D, Nuttall I, Nyenswah T, Olu O, Pendergast S, Perea W, Polonsky J, Riley S, Ronveaux O, Sakoba K, Santhana Gopala Krishnan R, Senga M, Shuaib F, Van Kerkhove MD, Vaz R, Wijekoon Kannangarage N, Yoti Z.

N Engl J Med. 2014 Oct 16;371(16):1481-95. doi: 10.1056/NEJMoa1411100. Epub 2014 Sep 22.

16.

Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data.

Garske T, Van Kerkhove MD, Yactayo S, Ronveaux O, Lewis RF, Staples JE, Perea W, Ferguson NM; Yellow Fever Expert Committee.

PLoS Med. 2014 May 6;11(5):e1001638. doi: 10.1371/journal.pmed.1001638. eCollection 2014 May.

17.

Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin.

Zipursky S, Djingarey MH, Lodjo JC, Olodo L, Tiendrebeogo S, Ronveaux O.

Vaccine. 2014 Mar 14;32(13):1431-5. doi: 10.1016/j.vaccine.2014.01.038. Epub 2014 Feb 19.

18.

Use of hub cutters and the volume of sharp waste and occurrence of needle-stick injuries during 2011 mass immunization campaigns against yellow fever in Ghana: a cohort study.

Agbenu E, Chartier Y, Eleeza J, Antwi-Agyei KO, Diamenu S, Ronveaux O, Perea W.

Int J Occup Environ Med. 2014 Jan;5(1):9-17.

19.

Diversity of picornaviruses in rural Bolivia.

Nix WA, Khetsuriani N, Peñaranda S, Maher K, Venczel L, Cselkó Z, Freire MC, Cisterna D, Lema CL, Rosales P, Rodriguez JR, Rodriguez W, Halkyer P, Ronveaux O, Pallansch MA, Oberste MS.

J Gen Virol. 2013 Sep;94(Pt 9):2017-28. doi: 10.1099/vir.0.053827-0. Epub 2013 Jun 26.

20.
21.

Putting safety first: ensuring safe vaccination practices during the 2006 rubella campaign in Bolivia.

Halkyer P, Azurduy R, Fuentes M, Van Dick AM, Ronveaux O.

J Infect Dis. 2011 Sep 1;204 Suppl 2:S718-21. doi: 10.1093/infdis/jir443.

PMID:
21954272
22.

Assessing the potency of oral polio vaccine kept outside of the cold chain during a national immunization campaign in Chad.

Zipursky S, Boualam L, Cheikh DO, Fournier-Caruana J, Hamid D, Janssen M, Kartoglu U, Waeterloos G, Ronveaux O.

Vaccine. 2011 Aug 5;29(34):5652-6. doi: 10.1016/j.vaccine.2011.06.011. Epub 2011 Jun 23.

PMID:
21699946
23.

Clustered lot quality assurance sampling: a pragmatic tool for timely assessment of vaccination coverage.

Greenland K, Rondy M, Chevez A, Sadozai N, Gasasira A, Abanida EA, Pate MA, Ronveaux O, Okayasu H, Pedalino B, Pezzoli L.

Trop Med Int Health. 2011 Jul;16(7):863-8. doi: 10.1111/j.1365-3156.2011.02770.x. Epub 2011 Apr 11.

24.

Clustered lot quality assurance sampling: a tool to monitor immunization coverage rapidly during a national yellow fever and polio vaccination campaign in Cameroon, May 2009.

Pezzoli L, Tchio R, Dzossa AD, Ndjomo S, Takeu A, Anya B, Ticha J, Ronveaux O, Lewis RF.

Epidemiol Infect. 2012 Jan;140(1):14-26. doi: 10.1017/S0950268811000331. Epub 2011 Mar 22.

PMID:
21418714
25.

Clustered lot quality assurance sampling to assess immunisation coverage: increasing rapidity and maintaining precision.

Pezzoli L, Andrews N, Ronveaux O.

Trop Med Int Health. 2010 May;15(5):540-6. doi: 10.1111/j.1365-3156.2010.02482.x. Epub 2010 Mar 8.

26.

Using oral polio vaccine beyond the cold chain: a feasibility study conducted during the national immunization campaign in Mali.

Halm A, Yalcouyé I, Kamissoko M, Keïta T, Modjirom N, Zipursky S, Kartoglu U, Ronveaux O.

Vaccine. 2010 Apr 26;28(19):3467-72. doi: 10.1016/j.vaccine.2010.02.066. Epub 2010 Mar 1.

PMID:
20197147
27.

Assessment of the quality of immunization data produced by the national individual registration system in Uruguay, 2006.

Ronveaux O, Arrieta F, Curto S, Laurani H, Danovaro-Holliday MC.

Rev Panam Salud Publica. 2009 Aug;26(2):153-60.

PMID:
19814895
28.

Cluster-sample surveys and lot quality assurance sampling to evaluate yellow fever immunisation coverage following a national campaign, Bolivia, 2007.

Pezzoli L, Pineda S, Halkyer P, Crespo G, Andrews N, Ronveaux O.

Trop Med Int Health. 2009 Mar;14(3):355-61. doi: 10.1111/j.1365-3156.2009.02231.x. Epub 2009 Jan 28.

29.

Accuracy and quality of immunization information systems in forty-one low income countries.

Bosch-Capblanch X, Ronveaux O, Doyle V, Remedios V, Bchir A.

Trop Med Int Health. 2009 Jan;14(1):2-10. doi: 10.1111/j.1365-3156.2008.02181.x.

30.

Design and simulation study of the immunization Data Quality Audit (DQA).

Woodard S, Archer L, Zell E, Ronveaux O, Birmingham M.

Ann Epidemiol. 2007 Aug;17(8):628-33. Epub 2007 Jun 6.

PMID:
17553701
31.

The immunization data quality audit: verifying the quality and consistency of immunization monitoring systems.

Ronveaux O, Rickert D, Hadler S, Groom H, Lloyd J, Bchir A, Birmingham M.

Bull World Health Organ. 2005 Jul;83(7):503-10.

32.

An outbreak of Legionnaire's disease among visitors to a fair in Belgium in 1999.

De Schrijver K, Dirven K, Van Bouwel K, Mortelmans L, Van Rossom P, De Beukelaar T, Vael C, Fajo M, Ronveaux O, Peeters MF, Van der Zee A, Bergmans A, Ieven M, Goossens H.

Public Health. 2003 Mar;117(2):117-24.

PMID:
12802978
33.

An outbreak of legionnaire s disease among visitors to a fair in Belgium, 1999.

De Schrijver K, Van Bouwel E, Mortelmans L, Van Rossom P, De Beukelaer T, Vael C, Dirven K, Goossens H, Leven M, Ronveaux O.

Euro Surveill. 2000 Nov;5(11):115-119.

PMID:
12631961
34.

Descriptive epidemiology of exanthems in the Rotterdam region January 1997 to June 1998.

Ronveaux O, Bosman A, Reintjes R, Conyn-Van Spaendonck MA.

Euro Surveill. 1998 Dec;3(12):122-124.

PMID:
12631924
35.

An outbreak of Norwalk like virus gastroenteritis in a nursing home in Rotterdam.

Ronveaux O, Vos D, Bosman A, Brandwijk K, Vinje J, Koopmans M, Reintjes R.

Euro Surveill. 2000 May;5(5):54-57.

PMID:
12631859
36.

Emergence of Enterobacter aerogenes as a major antibiotic-resistant nosocomial pathogen in Belgian hospitals.

Ronveaux O, Gheldre Y, Glupczynski Y, Struelens M, Mol P.

Clin Microbiol Infect. 1999 Oct;5(10):622-7. doi: 10.1111/j.1469-0691.1999.tb00419.x.

37.

A Campylobacter coli foodborne outbreak in Belgium.

Ronveaux O, Quoilin S, Van Loock F, Lheureux P, Struelens M, Butzler JP.

Acta Clin Belg. 2000 Nov-Dec;55(6):307-11.

PMID:
11484421
38.

National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998.

De Gheldre Y, Struelens MJ, Glupczynski Y, De Mol P, Maes N, Nonhoff C, Chetoui H, Sion C, Ronveaux O, Vaneechoutte M; Groupement pour le Dépistage, l'Etude et la Prevention des Infections Hospitalières (GDEPIH-GOSPIZ).

J Clin Microbiol. 2001 Mar;39(3):889-96.

39.

Potential susceptible individuals to poliomyelitis in Austria.

Kreidl P, Hladik W, Schoech J, Ronveaux O.

Eur J Epidemiol. 2000 Jun;16(6):519-20.

PMID:
11049094
40.

Evaluation of a transit first-aid station providing emergency care to former Yugoslavian war victims evacuated in Ancona, Italy.

Prospero E, Raffo M, Appignanesi R, Faccenda G, Ronveaux O, Annino, D'Errico MM.

Eur J Epidemiol. 2000 Mar;16(3):253-6.

PMID:
10870940
41.

Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals.

Crowcroft NS, Ronveaux O, Monnet DL, Mertens R.

Infect Control Hosp Epidemiol. 1999 Jan;20(1):31-6.

PMID:
9927263
42.

Epidemiology of nosocomial bloodstream infections in Belgium, 1992-1996.

Ronveaux O, Jans B, Suetens C, Carsauw H.

Eur J Clin Microbiol Infect Dis. 1998 Oct;17(10):695-700.

PMID:
9865982
43.

Surgical prophylaxis in Belgian hospitals: estimate of costs and potential savings.

Sasse A, Mertens R, Sion JP, Ronveaux O, Bossens M, De Mol P, Goossens H, Lauwers S, Potvliege C, Van Landuyt H, Verbist L, Verschraegen G.

J Antimicrob Chemother. 1998 Feb;41(2):267-72.

PMID:
9533470
44.

Infection registration underestimates the risk of surgical wound infection.

Mertens R, Ronveaux O.

J Hosp Infect. 1997 Dec;37(4):339-43. No abstract available.

PMID:
9457615
45.

Prevention of transmission of tuberculosis in hospitals; a survey of practices in Belgium, 1995.

Ronveaux O, Jans B, Wanlin M, Uydebrouck M.

J Hosp Infect. 1997 Nov;37(3):207-15.

PMID:
9421772
46.

Nosocomial bacteraemia life cost in Belgium.

Ronveaux O, Mertens R.

Acta Clin Belg. 1997;52(3):182. No abstract available.

PMID:
9350298
48.

Surgical wound infection surveillance: results from the Belgian hospital network.

Ronveaux O, Mertens R, Dupont Y.

Acta Chir Belg. 1996 Feb;96(1):3-10.

PMID:
8629385
49.

The role of communication in surgical wound infection surveillance.

Mertens R, Ronveaux O.

Acta Chir Belg. 1996 Feb;96(1):1-2. No abstract available.

PMID:
8629380
50.

[Methods in surgical antibacterial prophylaxis in Belgium, 1992-1995].

Ronveaux O, Mertens R, Jans B, Dupont Y.

Acta Clin Belg. 1996;51(6):386-94. French.

PMID:
9027189

Supplemental Content

Loading ...
Support Center